| 產(chǎn)品名稱 | A 1070722 |
| 產(chǎn)品貨號(hào) | Axon 1909 CAS [1384424-80-9] MF C17H13F3N4O2MW 362.31 Purity: 99% Soluble in DMSO Description Potent and selective glycogen synthase kinase GSK-3 inhibitor (Ki=6 nM). Brain penetrating and centrally active GSK-3 inhibitor for the treatment of psychiatric and neurodegenerative disorders References Certificates Categories Extra info MHM Bakker et al. A-1070722, a potent, selective, and centrally active glycogen synthase kinase-3 (GSK-3) inhibitor for the treatment of psychiatric and neurodegenerative disorders. Society for Neuroscience 2011, Abstract 568.04. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology CNS Diabetes & Metabolism Immunology Pain & Inflammation Stem Cell GSK-3 Wnt-β-Catenin PI3K-Akt-mTOR EC 2.7.11.26 Selective inhibitor of GSK-3 Chemical name 1-(7-methoxyquinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea Parent CAS No. [1384424-80-9] Order Size Unit Price Stock 5 mg €95.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
A 1070722Axon 1909 CAS [1384424-80-9] MF C17H13F3N4O2
Description
Potent and selective glycogen synthase kinase GSK-3 inhibitor (Ki=6 nM). Brain penetrating and centrally active GSK-3 inhibitor for the treatment of psychiatric and neurodegenerative disorders
Selective inhibitor of GSK-3
Chemical name1-(7-methoxyquinolin-4-yl)-3-(6-(trifluoromethyl)pyridin-2-yl)urea Parent CAS No.[1384424-80-9] |
| 產(chǎn)品資料 |
